Sands Lab Inc. (411080) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sands Lab Inc. (411080:KRX), powered by AI.

Current Price
₩5,240
P/E Ratio
-145.6
Market Cap
80.0B
Sector
Common Stock
What is the Sands Lab Inc. stock price forecast?

Sands Lab Inc. is currently trading at ₩5,240. View real-time AI analysis on Alpha Lenz.

What is Sands Lab Inc. insider trading activity?

View the latest insider trading data for Sands Lab Inc. on Alpha Lenz.

What is Sands Lab Inc.'s P/E ratio?

Sands Lab Inc.'s P/E ratio is -145.6.

Sands Lab Inc.

KRX · 411080
₩5,240-60(-1.13%)Market closedKRX regular session 09:00–15:30 KST
Ask about Sands Lab Inc.'s future dividend policy...
Alpha Chat Insight

Sands Lab Inc. trades at a P/E of -145.6 (undervalued) with modest ROE of -1.1%.

Ask for details

Company Overview

Sands Lab Inc. is a biotechnology company focusing on the research and development of innovative healthcare solutions. The company is specialized in creating advanced therapies and diagnostic tools that cater to the medical and pharmaceutical industries. With a commitment to improving patient outcomes, Sands Lab Inc. actively engages in pioneering research initiatives that aim to address unmet medical needs across various therapeutic areas, such as oncology, immunology, and infectious diseases. The firm employs cutting-edge technologies, including genomics, proteomics, and bioinformatics, to drive its product development pipeline. Sands Lab Inc. is well-regarded for its robust collaborations with leading academic and research institutions, further solidifying its position as a key player in the advancement of medical science. The company's contributions significantly impact the healthcare sector by enhancing treatment modalities and diagnostics, ultimately striving to elevate the quality of care available to patients globally. As biotechnology continues to expand its influence in the medical field, Sands Lab Inc. remains a critical contributor to the progress and innovation driving these advancements.

CEO김기홍
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩80,002,423,120Market Cap
₩11,612,082,340Revenue
15.27MShares Out
0Employees

Margins

100.00%Gross
3.32%EBITDA
-15.25%Operating
-0.32%Pre-Tax
-4.01%Net

Valuation

-145.55P/E
1.48P/B
6.89EV/Sales
120.10EV/EBITDA
-99.24P/FCF

Growth (CAGR)

7.68%Rev 3Yr
17.22%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.86%ROA
-1.08%ROE
-0.07%ROIC

Financial Health

₩34,012,562,000Cash & Cash Equivalents
₩-30,265,763,150Net Debt
6.90%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sands Lab Inc. (ticker: 411080) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $80.0B.

The current price is ₩5,240 with a P/E ratio of -145.55x and P/B of 1.48x.

ROE is -1.08% and operating margin is -15.25%. Annual revenue is $11.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sands Lab Inc. (411080) Stock Forecast 2026 ₩5,240 — Price, Financials & Analyst Targets | Alpha Lenz